diabetes management app

By Jonah Comstock February 16, 2017
Vienna and San Diego-based digital health company mySugr has come out of the International Conference on Advanced Technologies and Treatments for Diabetes with two big pieces of news: study results that show impressive efficacy of the app in high-risk populations and an expansion of its partnership with Roche. The study looked at 440 mySugr users randomly selected from a group of high-risk (HbA1C...
By Heather Mack February 16, 2017
Chronic disease management company Livongo is collaborating with Voluntis, the Paris, France-based company that develops companion apps for medical devices, to offer an integrated program, insulin delivery system and app for people with type 2 diabetes. Members will have access to the Livongo for Diabetes Program with Voluntis’ Insulia, the diabetes management app that received both FDA approval...
By Heather Mack January 30, 2017
Milpitas, California-based Bigfoot Biomedical, a diabetes management company working on their first product, announced an investment from the Juvenile Diabetes Research Foundation (JDRF)’s newly launched venture fund, T1D, focused on early stage companies working on type 1 diabetes. The terms of the investment were not disclosed, but Bigfoot previously raised $35.5 million. The funding will be...
By Heather Mack January 19, 2017
The US Food and Drug Administration has given the green light for a non-prescription version of BlueStar, WellDoc’s mobile diabetes management platform. Through this 510(k) class II clearance, WellDoc will now offer BlueStar and BlueStar Rx, allowing the company to offer the product through more channels. Both versions analyze diabetes data entered by the patient, comparing past data trends to...
By Heather Mack January 18, 2017
Minnesota-based Pops! Diabetes Care, which is working on a digital device and diabetes management platform, has raised a little over $1.2 million to bring its product to market. MedCity News confirmed the funding with Pops! CEO and cofounder Lonny Stormo, who previously served in executive roles at Medtronic. Last year, the company raised $500,000 from Minneapolis accelerator TreeHouse Health....
By Heather Mack January 5, 2017
Diabetes management device maker Intuity Medical has raised another $15 million in Series C funding in a round led by PTV Healthcare Capital, new investors KCK Group, and affiliates of Luther King Capital Management. Existing investors Accuitive Medical Ventures, Investor Growth Capital, US Venture Partners, Venrock and Versant Ventures also contributed to the round. The company, which makes an...
By Heather Mack December 8, 2016
Phoenix, Arizona-based Solera Health, which offers a platform that acts as an integrator for chronic disease management programs and services, announced the launch of new app to augment in-person delivery of diabetes prevention programs. Called SoleraONE, the app is designed for people who are participating in a community-based, in-person DPP. With the app, in-person DPP providers in the Solera...
By Heather Mack December 6, 2016
New York-based One Drop has received FDA clearance for its mobile blood glucose monitoring system, One Drop Chrome. The system consists of the Chrome Meter lancing device, test strips and a companion app, and is also now officially available with a monthly subscription service called One Drop Premium. People in the United States, UK and European Union can start ordering the $39.95 subscription...
By Heather Mack December 6, 2016
Paris, France and Cambridge, Massachusetts-based Voluntis, which makes companion software for medical devices or medications, has received both FDA clearance and the CE Mark for a type 2 diabetes management app called Insulia. The app, which is designed for people treated with basal insulin, is classified as a prescription-only medical device and will be available to patients and healthcare...
By Heather Mack November 17, 2016
Eli Lilly and Company has developed an app for people living with Type II diabetes who use Trulicity, the company’s once-per-week injectable diabetes medication that also works with a click-activated pen. The app, which has been fully functionally since September, is currently available free on iOS to anyone with a Trulicity prescription. “It’s important for people to successfully start any...